Skip to main content
SpringerLink
Log in

Subcutaneous epoetin offers significant advantages

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

An improved quality of life for patients with renal failure may be achieved by switching from IV to SC epoetin [erythropoietin]. Researchers at the recent 13th Annual Conference on Peritoneal Dialysis held in San Diego, US, described studies which demonstrated the advantages of this effective alternative.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Sean Henahan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henahan, S. Subcutaneous epoetin offers significant advantages. Inpharma Wkly. 885, 14 (1993). https://doi.org/10.2165/00128413-199308850-00031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199308850-00031

Search

Navigation